, /PRNewswire/ — In a transformative move set to redefine humanitarian operations in Pakistan, MindHYVE.ai™, a U.S.-based artificial intelligence company, has […]
Category: PRNewswire
Gen Announces Board Transitions, Welcomes John Chrystal as Peter Feld Departs
, /PRNewswire/ — Gen Digital Inc. (NASDAQ: GEN), a global leader dedicated to powering Digital Freedom, today announced the departure […]
Moatable Reports First Quarter 2025 Financial Results
, /PRNewswire/ — Moatable, Inc. (OTC Pink: MTBLY) (“Moatable” or the “Company”), a leading US-based SaaS company, today announced financial results […]
Une vétérane britannique de la technologie lance un programme de conseil stratégique et d’accompagnement pour donner un essor aux femmes cadres dans le domaine de la technologie
Le cadre de travail pour femmes cadres en 12 semaines de Padmasini Dayananda vise la réinvention de la carrière, la visibilité […]
Piramal Pharma Limited annonce ses résultats pour le quatrième trimestre et l’exercice 2025
, /PRNewswire/ — Piramal Pharma Limited (NSE : PPLPHARMA) (BSE : 543635), l’un des leaders mondiaux de l’industrie pharmaceutique et du […]
AT&T Announces Preliminary Results of 2025 Annual Meeting
, /PRNewswire/ — Final voting results will be posted to the AT&T Investor Relations website Key Takeaways: AT&T held its annual […]
U Power Limited Announces Filing of 2024 Annual Report with the U.S. Securities and Exchange Commission
, /PRNewswire/ — U Power Limited (Nasdaq: UCAR) (the “Company” or “U Power”), through its operating subsidiaries, is a vehicle […]
NASA Welcomes Norway as 55th Nation to Sign Artemis Accords
, /PRNewswire/ — Following an international signing ceremony Thursday, NASA congratulated Norway on becoming the latest country to join the […]
One Park Financial Once Again Honored with Sun Sentinel’s Top Workplaces Award for the 8th Time — Achieves Best Ranking Yet in 2025
Fired Up & Climbing Higher—One Park Scores 3rd Place and Wins Big with a Communication Award in the 2025 Sun […]
Alamar Biosciences élargit son panel 120 NULISAseq™ pour les maladies du système nerveux central (SNC) avec des tests sanguins innovants des protéines pTau dérivées du cerveau
Le premier panel de ce genre comprend des tests des protéines dérivées du cerveau pTau217, pTau181, pTau231 et tau totale pour […]